Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial.
benign prostatic hyperplasia
erectile dysfunction
lower urinary tract symptoms
medical therapy
tadalafil
tamsulosin
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
29 Jul 2019
29 Jul 2019
Historique:
received:
25
06
2019
revised:
17
07
2019
accepted:
25
07
2019
entrez:
1
8
2019
pubmed:
1
8
2019
medline:
1
8
2019
Statut:
epublish
Résumé
Tadalafil 5 mg represents the standard for men with Erectile dysfunction (ED) and lower urinary tract symptoms (LUTS)/benign prostatic enlargement (BPE). We carried out an observational trial aiming to assess the efficacy and safety of Tadalafil compared with Tadalafil plus Tamsulosin. Seventy-five patients complaining of ED and LUTS were treated for 12-weeks with Tadalafil plus placebo (TAD+PLA-group) or with combination therapy tadalafil plus tamsulosin (TAD+TAM-group). Efficacy variables were: International Index of Erectile Function (IIEF), International Prostate Symptom Score (IPSS), maximum urinary flow rate (Qmax) and safety assessments. Data were evaluated using paired samples
Identifiants
pubmed: 31362410
pii: jcm8081126
doi: 10.3390/jcm8081126
pmc: PMC6723816
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Urol. 1992 Nov;148(5):1549-57; discussion 1564
pubmed: 1279218
Urology. 2003 Nov;62(5 Suppl 2):3-10
pubmed: 14662401
J Urol. 2004 Nov;172(5 Pt 1):1935-40
pubmed: 15540759
Eur Urol. 2005 Jun;47(6):838-45
pubmed: 15925081
Endocrinology. 2007 Mar;148(3):1019-29
pubmed: 17138653
Eur Urol. 2007 Jun;51(6):1717-23
pubmed: 17258855
J Urol. 2007 Mar;177(3):1071-7
pubmed: 17296414
J Urol. 2007 Apr;177(4):1401-7
pubmed: 17382741
J Sex Med. 2008 Sep;5(9):2170-8
pubmed: 18638006
J Urol. 2008 Oct;180(4):1228-34
pubmed: 18722631
J Sex Med. 2009 Feb;6(2):544-52
pubmed: 19138360
J Sex Med. 2009 Mar;6(3):836-47
pubmed: 19143907
Int J Impot Res. 2009 Mar-Apr;21(2):122-8
pubmed: 19194451
J Sex Med. 2009 Jul;6(7):1794-808; quiz 1793, 1809-10
pubmed: 19575771
World J Urol. 2010 Feb;28(1):17-22
pubmed: 19855976
Urology. 2010 Jun;75(6):1452-8
pubmed: 20163842
BJU Int. 2011 Apr;107(7):1104-9
pubmed: 20883484
Int J Clin Pract. 2011 Sep;65(9):1005-13
pubmed: 21718399
Eur Urol. 2011 Oct;60(4):809-25
pubmed: 21726934
Eur Urol. 2011 Nov;60(5):1105-13
pubmed: 21871706
J Sex Med. 2012 Jan;9(1):271-81
pubmed: 21981682
Eur Urol. 2012 May;61(5):917-25
pubmed: 22297243
Eur Urol. 2012 May;61(5):994-1003
pubmed: 22405510
Int J Urol. 2013 Feb;20(2):193-201
pubmed: 22958078
Prostate. 2013 Mar;73(4):428-41
pubmed: 22996758
J Urol. 2013 Dec;190(6):2177-82
pubmed: 23727187
Prostate. 2013 Sep;73(13):1391-402
pubmed: 23765639
J Urol. 1985 Dec;134(6):1291-8
pubmed: 2414474
J Urol. 2014 Apr;191(4):1045-50
pubmed: 24445278
BJU Int. 2015 Jan;115(1):24-31
pubmed: 24602293
J Sex Med. 2014 Jun;11(6):1539-45
pubmed: 24621088
J Sex Med. 2014 Jun;11(6):1554-66
pubmed: 24708055
Eur Urol. 2016 Jul;70(1):124-133
pubmed: 26806655
Andrology. 2017 Jul;5(4):671-678
pubmed: 28453908
Ther Adv Urol. 2017 Dec 07;10(2):79-92
pubmed: 29434675
Br J Urol. 1995 Sep;76(3):325-36
pubmed: 7551841
Urology. 1997 Jun;49(6):822-30
pubmed: 9187685